Nancy Denyes, General Counsel at aTYR PHARMA INC (ATYR), sold 899 shares at $3.78 ($3K) on 2025-02-04, disclosed to the SEC on 2025-02-04.
Open-market sale of $3k ATYR by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LIFE | SELL | 2020-05-28 | $1K | — | Filing → |